Anticancer Agents : Design, Synthesis and Evaluation
| Anticancer Agents : Design, Synthesis and Evaluation |
| Autore | Chen Qiao-Hong |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (606 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
1,2,3-triazole
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide 3,6-dibromocarbazole 4-(pyridin-4-yloxy)benzamide 5-bromoindole 5-fluorouracil ABCB1 (P-glycoprotein) actin ADME allene amides/esters androgen receptor anti-cancer activity anti-neuroinflammation anti-ovarian cancer anti-tumor anticancer anticancer activity anticancer agent anticancer agents anticancer compounds antimitotic agents antioxidant activity antiproliferative activity antiproliferative agent antitumor antitumor activity apalutamide apoptosis aromatase benzimidazole benzofuran-pyrazole benzofurans beta-lapachone bivalency breast cancer c-Met carbazole cell cycle chemical synthesis chemoresistance chrysin analogues colchiceine colchicine amide colchicine analogs colchicine sulfonamide colon cancer computational docking coumarin crystal structure cyanopyridone cytotoxic activity cytotoxic properties cytotoxicity darolutamide DFT study dihydroartemisinin dihydropyranoindole docking docking studies drug discovery drug resistance E-stereoselective enzalutamide enzyme inhibition estrone derivatives flavonoid flavonoids gemcitabine HDAC inhibitors HeLa HepG2 hydrates hydrazine IGF-1R IL-12 immune modulation indoleamine 2,3-dioxygenase inflammation inhibitor K562 kinase inhibitor MCF-7 MDM2-p53 interaction migration mimetics molecular simulation MOLT-4 multidrug resistance (MDR) reversal N-substituted pyrazoline nanoparticles natural product neuroblastoma NIH3T3 o-nitro-benzyl organosilicon compounds ortho-quinones ovarian cancer overcoming drug resistance P-glycoprotein P-MAPA PARP inhibitor PARP-1 inhibition phenylpyrazolopyrimidine photoactivatable protecting groups PI3Ks PI3Kα inhibitor PI3Kδ inhibitors polyvalency prodrug prostate cancer PROTACs protein degradation protein kinase protein-protein interactions Pyrazole pyrazolopyridine pyridotriazine quinazolin-4(3H)-one quinazolin-4(3H)-thione regioselective salinomycin Schiff base SILA-409 (Alis-409) SILA-421 (Alis-421) Src substituted pyridine synergy synthesis Talazoparib tanshione IIA taxoids thiazolidinone Thienopyrimidine thienopyrimidinone thiocolchicine thiopene thioxotriazopyridine TLR signaling topoisomerase II inhibitor triazolothiadiazine triple-negative breast cancer tryptophan metabolism tubulin inhibitors tumor specificity urea virtual screening xanthones yeast-based assays zampanolide βIII-tubulin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Anticancer Agents |
| Record Nr. | UNINA-9910557129103321 |
Chen Qiao-Hong
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Natural Product from the Deep Sea
| Natural Product from the Deep Sea |
| Autore | Umezawa Kazuo |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (116 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
1H-15N 2D-NMR
abiotic formation Al-crus 3 and Al-crus 7 anti-Gram-negative bacteria anti-inflammatory agent antibacterial peptides anticancer agent antifungal activity antioxidant activity aplysinopsins bioactive metabolite biosynthetic gene clusters cellular signal transduction crustins deep sea marine-derived fungus deep-sea organisms deep-sea-derived fungus Deep-Sea-Derived Streptomyces desferrioxamine docking study genomics GNPS molecular network harziane diterpenes hydrothermal vent indoleamine 2,3-dioxygenase macrolactam Mariana Trench Micromonospora provocatoris MT25 Myrothecium sp myrothecol n-acetylglutaminyl glutamine amide natural product nitric oxide (NO) NO inhibition stress genes thioester-containing benzoate Thorectandra choanoides Trichoderma tryptophan alkaloid α-glucosidase inhibitory activity |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566476303321 |
Umezawa Kazuo
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Outcomes and Therapeutic Management of Bladder Cancer
| Outcomes and Therapeutic Management of Bladder Cancer |
| Autore | Moschini Marco |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (120 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adjuvant
age anesthesia recovery periods biomarkers bladder cancer chemotherapy clear-cell adenocarcinoma cognitive impairment female FOXA1 gamma-cyclodextrins GATA3 glycogen human epidermal growth factor receptor 2 immunotherapy indoleamine 2,3-dioxygenase intracorporeal neobladder KRT20 methylation molecular markers mRNA muscle-invasive bladder cancer n/a neoadjuvant neuromuscular blockade nodal disease open outcome outcomes PCR pN1 programmed death ligand-1 propensity score radical cystectomy robotic robotic radical cystectomy robotic-assisted SEER program database sex-sparing survival urinary bladder urothelial carcinoma |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557114503321 |
Moschini Marco
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||